scholarly journals A phase II evaluation of sunitinib in the treatment of persistent or recurrent clear cell ovarian carcinoma: An NRG Oncology/Gynecologic Oncology Group Study (GOG-254)

2018 ◽  
Vol 150 (2) ◽  
pp. 247-252 ◽  
Author(s):  
John K. Chan ◽  
William Brady ◽  
Bradley J. Monk ◽  
Jubilee Brown ◽  
Mark S. Shahin ◽  
...  
Keyword(s):  
Ovarian Carcinoma ◽  
Phase Ii ◽  
Clear Cell ◽  
Gynecologic Oncology ◽  
Gynecologic Oncology Group ◽  
Oncology Group ◽  
Oncology Group Study ◽  
Clear Cell Ovarian Carcinoma

Intraperitoneal Interferon-α in Residual Ovarian Carcinoma: A Phase II Gynecologic Oncology Group Study

1999 ◽  
Vol 75 (1) ◽  
pp. 10-14 ◽  
Author(s):  
Jonathan S. Berek ◽  
Maurie Markman ◽  
Bette Stonebraker ◽  
Samuel S. Lentz ◽  
Mark D. Adelson ◽  
...  
Keyword(s):  
Ovarian Carcinoma ◽  
Phase Ii ◽  
Gynecologic Oncology ◽  
Interferon Α ◽  
Gynecologic Oncology Group ◽  
Oncology Group ◽  
Oncology Group Study

A Phase II Study of Intraperitoneal Cisplatin and Thiotepa in Residual Ovarian Carcinoma: A Gynecologic Oncology Group Study

1998 ◽  
Vol 71 (3) ◽  
pp. 410-415 ◽  
Author(s):  
Lynn G. Feun ◽  
John A. Blessing ◽  
Francis J. Major ◽  
Philip J. DiSaia ◽  
Ronald D. Alvarez ◽  
...  
Keyword(s):  
Ovarian Carcinoma ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Gynecologic Oncology ◽  
Gynecologic Oncology Group ◽  
Oncology Group ◽  
Oncology Group Study

Intraperitoneal α-Interferon Alternating with Cisplatin in Residual Ovarian Carcinoma: A Phase II Gynecologic Oncology Group Study

1999 ◽  
Vol 74 (1) ◽  
pp. 48-52 ◽  
Author(s):  
Jonathan S. Berek ◽  
Maurie Markman ◽  
John A. Blessing ◽  
Paul R. Kucera ◽  
Beth E. Nelson ◽  
...  
Keyword(s):  
Ovarian Carcinoma ◽  
Phase Ii ◽  
Gynecologic Oncology ◽  
Gynecologic Oncology Group ◽  
Oncology Group ◽  
Oncology Group Study
Sign in / Sign up

Export Citation Format

Share Document